Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II two-stage study of MT1002 anticoagulation in hemodialysis patients
CTR20262331Phase 2Active
- Sponsor
- Shaanxi Micot Technology Co., Ltd.
- Start
- Jul 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MT1002 in end-stage kidney disease (ESKD), sponsored by Shaanxi Micot Technology Co., Ltd.. Started Jul 2026; status: active.
02
Drugs
MT1002
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on CTR20262331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262331.